Epidemiological studies play a pivotal role in the development of new uterotonic drugs. By analyzing data from diverse populations, researchers can identify patterns in drug efficacy and safety. These studies help in understanding the incidence and prevalence of PPH, the demographic factors influencing it, and the response to existing treatments.
